心力衰竭中的生活质量:新数据,新药和新设备
Katarzyna Major1, Aleksandra Bodys-Pełka2,3, Marcin Grabowski2
1Department of Noninvasive Cardiology, Medical University of Lodz, Poland. katarzyna.major@umed.lodz.pl.
Cardiology journal
|October 12, 2023
概括
新的药物治疗和设备可以改善心力衰竭患者的生活质量 (QoL). 这项研究回顾了基于证据的治疗方法,这些治疗方法会影响该群体的QoL.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医疗器械 医疗器械
背景情况:
- 生活质量 (QoL) 是心力衰竭管理中的一个关键结果指标.
- 基于证据的医学 (EBM) 提供各种疗法,以提高心力衰竭患者的QoL.
研究的目的:
- 提供关于新药疗法和新器械的数据.
- 评估这些新干预措施对心力衰竭的QoL的影响.
主要方法:
- 审查最近的临床数据和研究.
- 药物治疗剂的分析.
- 评估创新的设备技术.
主要成果:
- 新兴的药物疗法显示出改善QOL的潜力.
- 新的设备技术在增强患者福祉方面显示出前景.
- 数据突出了影响QOL结果的具体干预措施.
结论:
- 新的治疗方法正在扩大心力衰竭的治疗选择.
- 药物疗法和设备是提高质量生活的关键领域.
- 需要进一步的研究来优化心力衰竭管理中的QoL.
相关概念视频
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure Drugs: Diuretics
400
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
400


